Type 1 Autoimmune Pancreatitis: When a “Sausage-Shaped Pancreas” Mimics Pancreatic Cancer
A 60-Year-Old Man With Persistent Postprandial Upper Abdominal Pain
A 60-year-old man presented with approximately one month of persistent upper abdominal pain, particularly after meals. At first glance, postprandial abdominal pain may suggest common gastrointestinal disorders such as gastritis, gallstone disease, or functional dyspepsia.
However, the clinical picture becomes considerably more important when persistent abdominal pain is accompanied by abnormal hepatobiliary enzymes and pancreatic enlargement on contrast-enhanced CT.
In this case, the pancreas was diffusely enlarged and had a characteristic rounded, thickened “sausage-like” appearance. A low-attenuation capsule-like rim surrounded the pancreas. Endoscopic retrograde cholangiopancreatography (ERCP) demonstrated distal bile duct narrowing, while serum IgG4 was elevated. Histologic examination demonstrated lymphoplasmacytic infiltration, fibrosis, and chronic inflammation without evidence of malignancy.
Following glucocorticoid treatment, the pancreatic enlargement and biliary stricture resolved, the patient's postprandial pain disappeared, and hepatobiliary enzyme levels normalized.
Taken together, these findings formed a highly coherent clinical and radiologic pattern of Type 1 autoimmune pancreatitis (AIP), the pancreatic manifestation of IgG4-related disease.
The important lesson, however, is not simply that “elevated IgG4 means autoimmune pancreatitis.”
The real diagnostic challenge is recognizing when pancreatic enlargement represents an immune-mediated inflammatory process rather than pancreatic malignancy—and doing so without delaying the diagnosis of cancer.
What Is Type 1 Autoimmune Pancreatitis?
Type 1 autoimmune pancreatitis is an inflammatory pancreatic disease that is now regarded as a pancreatic manifestation of IgG4-related disease (IgG4-RD).
Unlike an isolated pancreatic disorder, IgG4-related disease can involve multiple organs, including the:
Pancreas
Bile ducts
Kidneys
Salivary glands
Lacrimal glands
Retroperitoneum
Lymph nodes
Lungs
Blood vessels
This systemic nature explains why evaluation should not stop after identifying pancreatic abnormalities.
Type 1 AIP is characterized pathologically by lymphoplasmacytic inflammation and fibrosis. Important histologic findings include storiform fibrosis and obliterative phlebitis. These inflammatory and fibrotic processes can enlarge and thicken the pancreas, producing the characteristic imaging appearance.
This distinction has major clinical importance because Type 1 AIP can closely resemble pancreatic ductal adenocarcinoma (PDAC).
A pancreatic mass should therefore not automatically be interpreted as cancer.
At the same time, the presence of imaging features suggestive of AIP should never be used as an excuse to dismiss a potentially malignant lesion.
Why This Case Matters in Radiology
The patient's presentation illustrates a common diagnostic problem in abdominal imaging.
The patient had:
Persistent postprandial upper abdominal pain
Mild elevation of ALT, AST, and ALP
No obvious jaundice
Diffuse pancreatic enlargement
Sausage-shaped pancreatic morphology
A capsule-like rim
Distal bile duct narrowing
Elevated serum IgG4
Histologic evidence of lymphoplasmacytic inflammation and fibrosis
Resolution after steroid treatment
The absence of jaundice is particularly important.
Although obstructive jaundice is a common clinical presentation of Type 1 AIP, not every patient develops jaundice. Therefore, the absence of jaundice does not exclude autoimmune pancreatitis.
From a radiologist's perspective, the combination of pancreatic and hepatobiliary abnormalities should prompt evaluation of the pancreas and bile ducts as a connected pathophysiologic system.
A useful clinical pattern is:
Older man + abdominal or back pain + hepatobiliary enzyme elevation + pancreatic enlargement + bile duct narrowing ± elevated IgG4
This combination should raise suspicion for Type 1 AIP.
The Imaging Hallmark: The Sausage-Shaped Pancreas
One of the most recognizable imaging manifestations of Type 1 AIP is diffuse pancreatic enlargement producing a sausage-like appearance.
On contrast-enhanced CT, the pancreas may become:
Diffusely enlarged
Rounded
Thickened
Relatively homogeneous
Less sharply contoured than a normal pancreas
A low-attenuation capsule-like rim may also surround the enlarged gland.
The combination of:
Diffuse pancreatic enlargement + sausage-shaped morphology + capsule-like rim
is a particularly important imaging clue.
Figure 1. Contrast-Enhanced CT of Type 1 Autoimmune Pancreatitis
Axial contrast-enhanced CT demonstrates diffuse pancreatic enlargement with a rounded, sausage-shaped configuration and a low-attenuation capsule-like rim.
Radiologic interpretation: The combination of diffuse pancreatic enlargement and a capsule-like rim is highly suggestive of Type 1 autoimmune pancreatitis in the appropriate clinical setting.
Important caveat: These findings are not independently diagnostic. Pancreatic malignancy, lymphoma, and other inflammatory pancreatic diseases must remain in the differential diagnosis.
Why Does the Pancreas Become Enlarged?
The characteristic morphology is not simply a consequence of nonspecific edema.
Type 1 AIP involves an inflammatory and fibrotic process that produces pancreatic enlargement.
A simplified pathophysiologic sequence is:
Lymphoplasmacytic infiltration → fibrosis → vascular inflammatory changes → pancreatic enlargement and ductal narrowing
The resulting fibrosis and inflammatory infiltration can increase the thickness and volume of pancreatic tissue.
This explains why a diffusely enlarged pancreas may resemble an infiltrative or neoplastic process.
For radiologists, this leads to an important principle:
Pancreatic enlargement does not automatically mean pancreatic cancer.
The morphology, enhancement characteristics, pancreatic duct, bile ducts, serum markers, histology, and extra-pancreatic findings must all be integrated.
CT Findings That Should Raise Suspicion for Type 1 AIP
The major CT findings described in this case include:
Diffuse pancreatic enlargement
Sausage-shaped pancreatic morphology
Capsule-like rim
Relatively homogeneous pancreatic parenchyma
Delayed enhancement
Long-segment pancreatic duct narrowing
Relatively limited upstream ductal dilatation
Penetrating duct sign
Bile duct stricture
Evidence of extra-pancreatic IgG4-related disease
These findings should not be evaluated independently.
The diagnostic value increases when several characteristic findings occur together.
The Penetrating Duct Sign: A Valuable Diagnostic Clue
The penetrating duct sign is another useful imaging feature.
It describes preservation of the pancreatic duct as it courses through an enlarged pancreatic region or mass-like lesion.
This finding can favor autoimmune pancreatitis over pancreatic ductal adenocarcinoma because a pancreatic duct that remains visible through a mass-like abnormality may indicate inflammatory enlargement rather than complete ductal destruction.
However, as with other imaging signs, the penetrating duct sign should be interpreted in combination with the entire clinical and imaging picture.
It is a diagnostic clue—not a standalone diagnosis.
Delayed Enhancement and Diffusion Restriction
Type 1 AIP may demonstrate delayed pancreatic enhancement, reflecting the inflammatory and fibrotic composition of the involved tissue.
MRI can provide additional information about pancreatic morphology, the pancreatic duct, and the bile ducts.
However, diffusion-weighted imaging requires particular caution.
Diffusion restriction can also occur in autoimmune pancreatitis.
Therefore:
Restricted diffusion ≠ pancreatic cancer
DWI is one component of multiparametric assessment and should not be used in isolation to distinguish AIP from malignancy.
MRI and MRCP: Looking Beyond the Pancreatic Parenchyma
MRI and MRCP provide complementary information about the pancreatic and biliary ducts.
One of the most important questions is the length and morphology of pancreatic duct narrowing.
In Type 1 AIP, a relatively long segment of pancreatic duct narrowing may occur.
By contrast, pancreatic ductal adenocarcinoma more commonly produces a short, irregular obstruction associated with upstream pancreatic duct dilatation.
MRCP is particularly useful because it can noninvasively demonstrate the pancreatic and biliary ductal anatomy.
The radiologist should therefore evaluate:
Main pancreatic duct caliber
Length of ductal narrowing
Upstream ductal dilatation
Penetrating duct sign
Distal bile duct narrowing
Intrahepatic and extrahepatic bile duct abnormalities
This duct-centered assessment can substantially improve interpretation of pancreatic enlargement.
When the Bile Duct Is Also Abnormal
The case demonstrated distal bile duct narrowing on ERCP.
This is clinically important because Type 1 AIP can coexist with IgG4-related sclerosing cholangitis.
Therefore, a distal bile duct stricture should not automatically be attributed to pancreatic cancer or cholangiocarcinoma.
The combination of:
Pancreatic enlargement + distal bile duct stricture + elevated IgG4
should raise the possibility of systemic IgG4-related disease involving the pancreas and biliary tract.
Figure 2. ERCP Demonstrating Distal Bile Duct Stricture
ERCP demonstrates narrowing of the distal bile duct in association with pancreatic involvement.
Clinical significance: The biliary abnormality should be interpreted together with the pancreatic imaging findings and the possibility of IgG4-related sclerosing cholangitis.
When significant biliary obstruction or obstructive jaundice is present, biliary drainage may become an important component of management.
Type 1 AIP Versus Pancreatic Cancer
This is the most important diagnostic problem.
Both Type 1 AIP and pancreatic cancer may occur in middle-aged or older adults and may produce:
Abdominal pain
Weight loss
Jaundice
Bile duct obstruction
Pancreatic enlargement or mass-like lesions
Consequently, imaging differentiation can be difficult, particularly in focal Type 1 AIP.
Imaging Features Favoring Type 1 AIP
| Feature | Type 1 AIP | Pancreatic Ductal Adenocarcinoma |
|---|---|---|
| Pancreatic enlargement | Often diffuse | Often focal |
| Sausage-shaped pancreas | Characteristic | Unusual |
| Capsule-like rim | Supports AIP | Uncommon |
| Ductal narrowing | Often long-segment | Often shorter and irregular |
| Upstream duct dilatation | May be relatively limited | Often prominent |
| Penetrating duct sign | Supports AIP | Less typical |
| Delayed enhancement | May be present | Not characteristic |
| IgG4 elevation | Supports AIP | May occur in some cases |
| Steroid response | Strong | Not expected |
These distinctions are useful, but none should be interpreted as an absolute rule.
The crucial principle is:
An imaging pattern suggestive of AIP does not automatically exclude pancreatic cancer.
The IgG4 Trap
Serum IgG4 is an important component of the diagnostic evaluation of Type 1 AIP.
However, one of the most dangerous simplifications is:
“Elevated IgG4 = autoimmune pancreatitis.”
That equation is incorrect.
Elevated serum IgG4 supports the diagnosis but is not sufficient by itself to establish it. Conversely, a normal serum IgG4 level does not completely exclude IgG4-related disease.
The international consensus diagnostic approach integrates:
Pancreatic parenchymal imaging
Pancreatic duct imaging
Serology
Other-organ involvement
Histopathology
Steroid response when appropriate
rather than relying on a single laboratory value.
This is a critical example of why radiologic diagnosis should be based on pattern integration rather than isolated findings.
Histopathology: Why a Negative Cancer Result May Not Be Enough
In this case, pancreatic needle biopsy was limited by crush artifact.
Nevertheless, lymphoplasmacytic infiltration, fibrosis, and chronic inflammation were identified, while malignancy was not demonstrated.
This finding is clinically meaningful but must be interpreted carefully.
Small tissue samples may fail to demonstrate all of the characteristic histologic features of Type 1 AIP.
Fine-needle aspiration may also have limitations when the diagnostic question depends on evaluating architectural features such as extensive fibrosis and vascular involvement.
Therefore, pathology should not always be reduced to a simple binary interpretation:
Cancer positive vs. cancer negative
The adequacy of the specimen and the clinical-radiologic context matter.
If the imaging strongly suggests Type 1 AIP but the biopsy is nondiagnostic, multidisciplinary correlation may be required.
The Differential Diagnosis of a Diffusely Enlarged Pancreas
When the pancreas is enlarged, several diagnoses should be considered.
1. Pancreatic Ductal Adenocarcinoma
The most important differential diagnosis.
Focal pancreatic enlargement, an irregular short ductal obstruction, marked upstream ductal dilatation, and a typical malignant clinical context may favor PDAC.
2. Chronic Pancreatitis
Chronic pancreatitis more commonly demonstrates:
Pancreatic atrophy
Calcification
Irregular pancreatic duct changes
Ductal dilatation
These findings differ from the relatively homogeneous pancreatic enlargement that can characterize Type 1 AIP.
3. Type 2 Autoimmune Pancreatitis
Type 2 AIP is a distinct form of autoimmune pancreatitis and does not have the same close association with systemic IgG4-related disease as Type 1 AIP.
4. Pancreatic Lymphoma
Pancreatic lymphoma can produce substantial pancreatic enlargement or a large mass.
A relatively limited degree of pancreatic duct obstruction despite substantial tumor burden may provide a clue, while lymphadenopathy and extra-pancreatic disease should also be assessed.
5. Metastatic Disease and Other Infiltrative Disorders
Metastatic lesions and other inflammatory or infiltrative diseases can also alter pancreatic morphology.
The differential diagnosis should therefore remain broad until clinical, imaging, laboratory, and pathologic evidence converge.
A Practical Radiology Checklist
When Type 1 AIP is suspected, a structured interpretation can be particularly useful.
Ten Questions to Ask
1. Is the pancreas diffusely enlarged?
2. Does it have a sausage-like configuration?
3. Is a capsule-like rim present?
4. Is pancreatic duct narrowing short or long?
5. Does the pancreatic duct penetrate the enlarged region?
6. Is delayed enhancement present?
7. Is there a bile duct stricture?
8. Are there abnormalities in the kidneys, retroperitoneum, salivary glands, liver, or other organs?
9. Is serum IgG4 elevated?
10. Has pancreatic malignancy been adequately considered and excluded?
This approach moves the interpretation beyond the nonspecific statement of “pancreatic enlargement” and toward an integrated diagnostic assessment.
Treatment: Why Glucocorticoids Matter
One of the defining clinical characteristics of Type 1 AIP is its strong response to glucocorticoid therapy.
For symptomatic disease, particularly when pancreatic or biliary obstruction is present, steroid treatment may be considered.
The general therapeutic sequence is:
Steroid induction → clinical, biochemical, and imaging assessment → gradual tapering → maintenance therapy when appropriate
The source case describes treatment with gradually tapered prednisolone. At two-month follow-up, pancreatic enlargement and the intrapancreatic bile duct stricture had resolved. The patient's postprandial abdominal pain disappeared, and hepatobiliary enzyme levels normalized.
This represents a highly characteristic treatment response.
However, steroid responsiveness must be interpreted carefully.
A good steroid response should not be used as the initial justification for ignoring a possible pancreatic malignancy.
If cancer has not been adequately evaluated, empirical steroid treatment may potentially delay appropriate oncologic management.
The Follow-Up Scan Can Be as Important as the Initial Scan
The follow-up imaging in this case is particularly instructive.
After steroid treatment:
Pancreatic enlargement resolved
Bile duct narrowing resolved
Postprandial pain disappeared
Hepatobiliary enzymes normalized
The imaging response provided additional evidence supporting the inflammatory nature of the disease.
For radiologists, this illustrates an important concept:
Imaging is not only diagnostic at presentation; it can also document the biologic response to treatment.
Nevertheless, treatment response should remain one component of an integrated diagnostic process.
Type 1 AIP Is Not Simply a “One-Time” Pancreatitis
Another major clinical issue is relapse.
Even after symptoms and imaging abnormalities have completely resolved, Type 1 AIP can recur.
The case source cites a systematic review and meta-analysis of 36 studies reporting an overall relapse rate of approximately 33% for autoimmune pancreatitis, with a higher relapse rate of approximately 37.5% in Type 1 AIP.
Long-term maintenance steroid therapy may reduce relapse in selected patients.
A randomized controlled trial cited in the case found that the three-year relapse rate was 23.3% among patients receiving 5–7.5 mg/day of prednisolone maintenance therapy, compared with 57.9% among patients in whom treatment was discontinued early.
These findings emphasize an important distinction:
Clinical remission is not necessarily the same as permanent cure.
Long-Term Prognosis
Type 1 AIP generally demonstrates an excellent initial response when correctly diagnosed and appropriately treated.
However, long-term follow-up remains important because patients may develop:
Recurrent autoimmune pancreatitis
Recurrent bile duct strictures
Additional IgG4-related organ involvement
Diabetes mellitus
Pancreatic exocrine dysfunction
Steroid-related adverse effects
Need for long-term immunomodulatory treatment
Thus, Type 1 AIP can be summarized as a disease with:
Excellent short-term treatment responsiveness but meaningful long-term surveillance requirements.
Seven CT Findings You Should Never Miss
When reviewing a pancreatic CT in an older patient with unexplained abdominal symptoms, seven findings deserve particular attention:
1. Sausage-shaped pancreas
Diffuse, rounded pancreatic enlargement is a classic clue.
2. Capsule-like rim
A peripheral low-attenuation rim supports the diagnosis in the appropriate setting.
3. Long-segment pancreatic duct narrowing
The length and morphology of ductal narrowing can help distinguish inflammatory disease from malignancy.
4. Penetrating duct sign
Preservation of the pancreatic duct through an enlarged region can support AIP.
5. Delayed enhancement
Delayed enhancement may reflect the fibrotic and inflammatory nature of the disease.
6. Bile duct stricture
Distal bile duct narrowing may indicate associated IgG4-related sclerosing cholangitis.
7. Extra-pancreatic IgG4-related disease
Renal, retroperitoneal, salivary gland, lymph node, and other organ abnormalities can provide important systemic clues.
When several of these findings coexist, the probability of Type 1 AIP rises substantially.
The Most Important Lesson From This Case
The most valuable aspect of this case is not simply the elevated IgG4 level.
The diagnosis became convincing because multiple independent findings converged on the same pathophysiologic explanation.
The patient was an older man with persistent postprandial upper abdominal pain and abnormal hepatobiliary enzymes.
CT demonstrated diffuse pancreatic enlargement, a sausage-shaped configuration, and a capsule-like rim.
ERCP demonstrated distal bile duct narrowing.
Histology demonstrated lymphoplasmacytic infiltration, fibrosis, and chronic inflammation without malignancy.
Serum IgG4 was elevated.
Finally, steroid treatment resulted in resolution of the pancreatic enlargement and biliary stricture, disappearance of symptoms, and normalization of hepatobiliary enzymes.
This is an excellent example of:
Pattern recognition + clinical correlation
in abdominal radiology.
A Diagnostic Algorithm for Suspected Type 1 AIP
This multi-domain strategy is consistent with the integrated diagnostic philosophy of the International Consensus Diagnostic Criteria.
Three Clinical Questions Every Radiologist Should Be Able to Answer
Question 1. Does a sausage-shaped pancreas mean autoimmune pancreatitis?
It strongly raises suspicion for Type 1 AIP, particularly when accompanied by a capsule-like rim and other characteristic findings. However, it is not an isolated diagnostic criterion.
Question 2. Does elevated IgG4 prove Type 1 AIP?
No.
Serum IgG4 is an important supportive finding but must be interpreted together with imaging, histology, and extra-pancreatic manifestations.
Question 3. Does steroid response exclude pancreatic cancer?
No.
A steroid response may strongly support AIP in the correct context, but malignancy should be adequately considered before using steroid response as a diagnostic argument.
Take-Home Message
Type 1 autoimmune pancreatitis is a particularly important diagnosis in abdominal imaging because it occupies a difficult diagnostic intersection between inflammation, fibrosis, systemic immune disease, and pancreatic malignancy.
The most useful imaging pattern is:
Sausage-shaped pancreas + capsule-like rim + long-segment pancreatic duct narrowing + elevated IgG4
When distal bile duct narrowing and extra-pancreatic IgG4-related abnormalities are also present, the diagnostic picture becomes even more compelling.
But the central lesson is more sophisticated than recognizing a classic imaging sign.
A radiologist should ask:
“Why is this pancreas enlarged?”
rather than simply:
“Is this a pancreatic mass?”
The answer requires integration of pancreatic morphology, pancreatic duct findings, biliary abnormalities, enhancement characteristics, serum IgG4, histopathology, extra-pancreatic disease, and—when appropriate—response to treatment.
Type 1 AIP is highly treatable, but its close resemblance to pancreatic cancer makes accurate diagnosis essential.
The ultimate goal is to avoid both major errors:
missing pancreatic cancer by assuming autoimmune disease, and performing unnecessary cancer-directed surgery for a steroid-responsive inflammatory disease.
That balance is the essence of high-quality pancreatic imaging.
Medical Disclaimer
This column is intended for educational and informational purposes only and does not replace professional medical diagnosis, treatment, or consultation.
The clinical decisions described in this article should not be applied to an individual patient without appropriate evaluation by qualified medical professionals. Patients with pancreatic enlargement, abdominal pain, jaundice, abnormal liver or pancreatic enzymes, or suspected pancreatic malignancy should undergo individualized assessment by an appropriate specialist.
References
[1] T. Shimosegawa et al., “International consensus diagnostic criteria for autoimmune pancreatitis: Guidelines of the International Association of Pancreatology,” Pancreas, vol. 40, no. 3, pp. 352–358, 2011. doi: 10.1097/MPA.0b013e3182142fd2.
[2] L. Zhang et al., “Autoimmune pancreatitis (AIP) type 1 and type 2: An international consensus study on histopathologic diagnostic criteria,” Pancreas, vol. 40, no. 8, pp. 1172–1179, 2011. doi: 10.1097/MPA.0b013e318233bec5.
[3] H. Ogawa, Y. Takehara, and S. Naganawa, “Imaging diagnosis of autoimmune pancreatitis: Computed tomography and magnetic resonance imaging,” Journal of Medical Ultrasonics, vol. 48, pp. 565–571, 2021. doi: 10.1007/s10396-021-01145-8.
[4] L. K. Lee and D. V. Sahani, “Autoimmune pancreatitis in the context of IgG4-related disease: Review of imaging findings,” World Journal of Gastroenterology, vol. 20, no. 41, pp. 15177–15189, 2014. doi: 10.3748/wjg.v20.i41.15177.
[5] K. Okazaki et al., “International consensus for the treatment of autoimmune pancreatitis,” Pancreatology, vol. 17, no. 1, pp. 1–6, 2017. doi: 10.1016/j.pan.2016.12.003.
[6] A. Masamune et al., “Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis,” Gut, vol. 66, no. 3, pp. 487–494, 2017. doi: 10.1136/gutjnl-2016-312049.
[7] M. Tacelli et al., “Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis,” Clinical Gastroenterology and Hepatology, vol. 17, no. 6, pp. 1061–1072.e8, 2019. doi: 10.1016/j.cgh.2018.09.051.
[8] K. Kubota et al., “Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: A long-term Japanese multicenter analysis of 510 patients,” Digestive and Liver Disease, vol. 52, no. 8, pp. 955–964, 2017. doi: 10.1007/s00535-016-1302-1.
Comments
Post a Comment